Shanghai Aladdin Biochemical Technology Co.,Ltd. Stock
Equities
688179
CNE100005XD0
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.01 CNY | -0.82% | +6.11% | -11.22% |
Sales 2024 * | 512M 70.86M | Sales 2025 * | 661M 91.48M | Capitalization | 3.37B 466M |
---|---|---|---|---|---|
Net income 2024 * | 177M 24.5M | Net income 2025 * | 228M 31.55M | EV / Sales 2024 * | 6.58 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.1 x |
P/E ratio 2024 * |
13.6
x | P/E ratio 2025 * |
10.6
x | Employees | 566 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.04% |
1 day | -0.82% | ||
1 week | +6.11% | ||
Current month | +6.11% | ||
1 month | +13.40% | ||
3 months | +30.65% | ||
6 months | -20.03% | ||
Current year | -11.22% |
Managers | Title | Age | Since |
---|---|---|---|
Jiu Zhen Xu
CEO | Chief Executive Officer | 58 | - |
Hong Bao Shen
DFI | Director of Finance/CFO | 41 | - |
Wei Yu Gu
DFI | Director of Finance/CFO | 49 | 11-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xin An Zhao
BRD | Director/Board Member | 55 | 13-10-31 |
Jiu Zhen Xu
CEO | Chief Executive Officer | 58 | - |
Kun Wang
ADM | Chief Administrative Officer | 44 | 11-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 17.01 | -0.82% | 5,275,522 |
24-05-07 | 17.15 | +1.00% | 3,822,123 |
24-05-06 | 16.98 | +5.93% | 5,428,212 |
24-04-30 | 16.03 | -2.61% | 3,620,429 |
End-of-day quote Shanghai S.E., May 07, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.22% | 466M | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |
- Stock Market
- Equities
- 688179 Stock